This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.
This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Madagascar. It will be implemented by Marie Stopes Madagascar with technical support from Marie Stopes International and FHI. 300 women of reproductive age who selected Zarin as their primary method of contraception will be enrolled in the study at the MSM outreach sites and static clinics.
Study Type
OBSERVATIONAL
Enrollment
621
Marie Stopes Madagascar Mobile Outreach Sites and Static Clinics
Madagascar, Madagascar
The cumulative probability of pregnancy through one year
Time frame: 1 year
Prevalence and incidence rate of adverse events
Time frame: 1 year
Prevalence and incidence rates of immediate and delayed complications associated with insertion or removal
Time frame: 1 year
The cumulative probability of early discontinuation through one year
Time frame: 1 year
Reasons for discontinuation
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.